World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
52
Citations
17879
World Ranking
5212
National Ranking
2331

Best Publications

  • Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease

    Timothy R. Sampson;Justine W. Debelius;Taren Thron;Stefan Janssen

  • A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease†

    C. Warren Olanow;Christopher G. Goetz;Jeffrey H. Kordower;A. Jon Stoessl

  • Increased Intestinal Permeability Correlates with Sigmoid Mucosa alpha-Synuclein Staining and Endotoxin Exposure Markers in Early Parkinson's Disease

    Christopher B. Forsyth;Kathleen M. Shannon;Jeffrey H. Kordower;Robin M. Voigt

  • Prevalence of Parkinsonian Signs and Associated Mortality in a Community Population of Older People

    David A. Bennett;Laurel A. Beckett;Anne M. Murray;Kathleen M. Shannon

  • Practice Parameter: Evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology

    D Aarsland;M Emre;A Lees;W Poewe

  • Is alpha-synuclein in the colon a biomarker for premotor Parkinson's Disease? Evidence from 3 cases†‡§

    Kathleen M. Shannon;Ali Keshavarzian;Hemraj B. Dodiya;Shriram Jakate

  • Role of TLR4 in the gut-brain axis in Parkinson’s disease: a translational study from men to mice

    Paula Perez-Pardo;Hemraj B Dodiya;Phillip A Engen;Christopher B Forsyth

  • Efficacy of pramipexole, a novel dopamine agonist, as monotherapy in mild to moderate Parkinson's disease

    Shannon Km;Bennett Jp;Friedman Jh

  • A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease

    I. H. Richard;M. P. McDermott;R. Kurlan;J. M. Lyness

  • Multicenter Study of Autologous Adrenal Medullary Transplantation to the Corpus Striatum in Patients with Advanced Parkinson's Disease

    Christopher G. Goetz;C. Warren Olanow;William C. Koller;Richard D. Penn

  • Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease.

    Leo P. Kelly;Paul M. Carvey;Ali Keshavarzian;Kathleen M. Shannon

  • Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.

    Hemraj B. Dodiya;Christopher B. Forsyth;Robin M. Voigt;Phillip A. Engen

  • Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia.

    C. L. Comella;J. Jankovic;K. M. Shannon;J. Tsui

  • An R5L τ mutation in a subject with a progressive supranuclear palsy phenotype

    Parvoneh Poorkaj;Nancy A. Muma;Victoria Zhukareva;Elizabeth J. Cochran

  • Clonidine and Gilles de la Tourette's syndrome: Double‐blind study using objective rating methods

    C G Goetz;C M Tanner;R S Wilson;V S Carroll

  • Metric properties of nurses' ratings of parkinsonian signs with a modified Unified Parkinson's Disease Rating Scale

    D. A. Bennett;K. M. Shannon;L. A. Beckett;C. G. Goetz

  • Effect of Creatine Monohydrate on Clinical Progression in Patients With Parkinson Disease A Randomized Clinical Trial

    Karl Kieburtz;Barbara C. Tilley;Jordan J. Elm;Debra Babcock

  • The current clinical management of Huntington's disease.

    Wendy Phillips;Kathleen M. Shannon;Roger A. Barker

  • Stereotactic pallidotomy for the treatment of Parkinson's disease Efficacy and adverse effects at 6 months in 26 patients

    K. M. Shannon;R. D. Penn;J. S. Kroin;C. H. Adler

  • A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease

    Andrew McGarry;Michael McDermott;Karl Kieburtz;Elisabeth A. DeBlieck

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: